Six women who received the Johnson & Johnson COVID-19 vaccine reportedly suffered blood clots after vaccination

The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In this March 25, 2021 file photo, a box of the Johnson & Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. (AP Photo/Ted S. Warren)

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow.

Johnson & Johnson Vaccine Begins Shipment After FDA Authorizes Emergency Use
Doses of the Johnson & Johnson COVID vaccine is packaged in a box at the McKesson facility on March 1, 2021 in Shepherdsville, Kentucky. (Photo by Timothy D. Easley-Pool/Getty Images)

CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.

Have you subscribed to theGrio’s “Dear Culture” podcast? Download our newest episodes now!

TheGrio is now on Apple TV, Amazon Fire and Roku. Download theGrio.com today!

The post US recommends ‘pause’ for Johnson & Johnson vaccine over clot reports appeared first on TheGrio.